GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.4%1-day move

₹2422.20

prior close

₹2481.10

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.1+0.1+0.2+2.4+0.6+1.0-0.5-0.4-1.3-8.8-9.9-0.6—

Up moveDown movePending

AI summary

GlaxoSmithKline Pharmaceuticals has informed stock exchanges about a scheduled group meeting with investors and analysts on 13th May 2026. The meeting will be held digitally via online format. This disclosure is made under SEBI Listing Regulations (Regulation 30) as a routine compliance requirement. The company clarified that only information already in public domain will be shared during the interaction. The meeting date may change due to exigencies on either party's side.

Likely market impact

This is a standard regulatory disclosure with no immediate impact on the stock. It indicates management engagement with institutional investors, which is routine for listed companies.